Company Profile
SAFC Biosciences provides an integrated services package in mammalian cell culture media development to support customer programs from pre-clinical and clinical development through to commercialization. Analytical and regulatory support is also part of the package to directly benefit speed-to-market times.
Headquartered in Lenexa, Kansas, SAFC Biosciences has six production facilities in the US, Europe and Australia and employs 600 people. Main product lines are EX-CELL™ serum-free media; serum-based products; LONG™ growth factors and BIOEAZE™ disposable bioprocessing systems.
As the basis for its biopharmaceutical expansion program, Sigma-Aldrich acquired JRH Biosciences from Australia's CSL Limited in February 2005 creating SAFC Biosciences.
Reviews
No reviews to display
Latest news
News
SAFC Expands PharmaGrade Raw Materials Portfolio
07 Mar 2013
-
SAFC Launches CHOZN ZFN-modified CHO Cell Lines to Enhance Speed of Bioproduction
08 Jul 2011
-
SAFC Announces Launch of Raw Materials and Custom Services Developed Specifically for Point-of-Care Diagnostics Manufacture
15 Mar 2011
-
New Ex-Cell® Antifoam From SAFC Biosciences Increases Consistency in Cell Culture Manufacturing
19 Nov 2009
-
SAFC Appointed By Curalogic to Provide Chemical Development Services
27 Oct 2006
